Abstract: The present invention relates to a process for stabilizing aqueous preparations of minerals by adding reuterin to the aqueous preparations, to the use of reuterin for the stabilization of such aqueous mineral preparations, and the aqueous mineral preparations containing reuterin.

Abstract: The present invention relates to a process for stabilizing aqueous preparations of minerals by adding reuterin to the aqueous preparations, to the use of reuterin for the stabilization of such aqueous mineral preparations, and the aqueous mineral preparations containing reuterin.

Abstract: The present invention relates to the use of at least one nucleic acid comprising or consisting of: (i) CATCGAT-GAAGAACGCWGCRAAHTGCGATAMGTARTGYGAATTGCAGRATTCAGTGARTCATCGAAWYTTTGAACG-CAYMTTGCRC (SEQ ID NO: 1), wherein: R represents A or G Y represents C or T M represents A or C W represents A or T H represents A or C or T (ii) a portion of SEQ ID NO: 1, provided said nucleic acid binds under stringent conditions to a nucleic acid comprising or consisting of the complementary sequence of SEQ ID NO: 1, or (iii) complementary sequences of (i) and (ii); for the detection of nucleic acids from one or more fungi in a sample.

Abstract: The present invention refers to a process for bacterial stabilizing aqueous preparations like e.g. calcium carbonate slurries and a composition which can be used for the biocidal treatment of such aqueous preparations.

Abstract: The present invention discloses an aqueous phenolates-containing liquid formulation having a solidification point of less than or equal to ?10° C. which is characterized by comprising the following components: a) 50-80% by wt. of one or more phenolates; b) 0.1-10% by wt. of at least one crystallization inhibitor; and water and optionally other components forming the balance.

Abstract: The present invention discloses an aqueous phenolates-containing liquid formulation having a solidification point of less than or equal to ?10° C. which is characterized by comprising the following components: a) 50-80% by wt. of one or more phenolates; b) 0.1-10% by wt. of at least one crystallization inhibitor; and water and optionally other components forming the balance.

Abstract: The present invention discloses an aqueous phenolates-containing liquid formulation having a solidification point of less than or equal to ?10° C. which is characterized by comprising the following components: a) 50-80% by wt. of one or more phenolates; b) 0.1-10% by wt. of at least one crystallization inhibitor; and water and optionally other components forming the balance.

Abstract: The present invention discloses an aqueous phenolates-containing liquid formulation having a solidification point of less than or equal to ?10° C. which is characterized by comprising the following components: a) 50–80% by wt. of one or more phenolates; b) 0.1–10% by wt. of at least one crystallization inhibitor; and water and optionally other components forming the balance.

Abstract: The present invention discloses an aqueous phenolates-containing liquid formulation having a solidification point of less than or equal to −10° C.

Abstract: The present invention discloses a process for quantitative and/or qualitative determination of the microbial contamination of suspensions, emulsions or dispersions containing minerals and/or pigments and/or fillers and/or fiber materials wherein following the addition of one or more substances which can be degraded by microorganisms, mixing and optionally subsequent incubation a sample of the suspensions, emulsions or dispersions is centrifuged to separate the microorganisms from the minerals and/or fillers and/or pigments and/or fiber materials and the number and/or size and/or type of the microorganisms is determined in the aqueous supernatant phase after one or more incubations.

Abstract: The present invention relates to an aqueous formulation containing phenol and/or phenol derivatives having a low freezing point and anti-microbial activity.